FDA authorizes new COVID-19 saliva test pioneered by Yale, the NBA
DETROIT – The Food and Drug Administration (FDA) has granted emergency use authorization for Yale University’s coronavirus test, Saliva Direct. Saliva Direct uses a simplified testing method that cuts the turnaround time to less than 24 hours. Researchers said the accuracy of the Saliva Direct results matched almost perfectly with the group’s swab tests. The Saliva Direct test is simple enough to be used by labs everywhere, once they go through the required accreditation process. Yale and the NBA do not intend to take any royalties from the testing method, making it available for free.